Leading clinicians and scientists from North Shore LIJ have provided a significant quantity of clinical specimens in a study of chronic lymphocytic leukemia (CLL) that were used for the clinical validation of CGI’s proprietary microarray, MatBA® -CLL. CGI analyzed these samples in-house and published the resulting data jointly. CGI will use the same samples for additional collaborative studies involving the search for additional molecular biomarkers of CLL.